Skip to main content
Raju (Radha) Pillai, MD, Pathology, Duarte, CA

Raju K (Radha) Pillai MD

Hematopathology, Molecular Genetics, Anatomic Pathology, Clinical Pathology


Hematopathologist and Director, Pathology Bioinformatics

Join to View Full Profile
  • 1500 Duarte RdDuarte, CA 91010

  • Phone+1 626-256-4673

  • Fax+1 626-218-5310

Dr. Pillai is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Summary

  • I am a board-certified hematopathologist and molecular pathologist.

Education & Training

  • UPMC Medical Education
    UPMC Medical EducationFellowship, Hematopathology, 2010 - 2012
  • UPMC Medical Education
    UPMC Medical EducationFellowship, Molecular Genetic Pathology, 2009 - 2010
  • University of Southern California/Los Angeles General Medical Center (USC/LA General)
    University of Southern California/Los Angeles General Medical Center (USC/LA General)Residency, Pathology-Anatomic and Clinical, 2005 - 2009
  • Calicut Medical College
    Calicut Medical CollegeClass of 1993

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2008 - 2026
  • PA State Medical License
    PA State Medical License 2009 - 2016
  • Pathology - Anatomic/Pathology - Clinical
    American Board of Pathology Pathology - Anatomic/Pathology - Clinical
  • Pathology - Molecular Genetic
    American Board of Pathology Pathology - Molecular Genetic
  • Hematopathology
    American Board of Pathology Hematopathology

Publications & Presentations

PubMed

Journal Articles

  • ERα-Mediated Cell Cycle Progression Is an Important Requisite for CDK4/6 Inhibitor Response in HR+ Breast Cancer  
    Joanne Mortimer, Laura Kruper, Raju Pillai, George Somlo, Yuan Yuan, Oncotarget

Abstracts/Posters

  • Whole Exome and Transcriptome Sequencing in 1042 Cases Reveals Distinct Clinically Relevant Genetic Subgroups of Follicular Lymphoma
    Raju Pillai, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019

Lectures

  • MIPSS70+ V2.0 and Revised Cytogenetics Changes Predict Outcomes of Allogeneic Transplantation with Fludarabine and Melphalan Conditioning in Patients with Myelofibrosis 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
  • Intralesional Administration of the CD47 Antagonist TTI-621 (SIRPαFc) Induces Responses in Both Injected and Non-Injected Lesions in Patients with Relapsed/Refractory ... 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: